Letter to the Editor
Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?”

https://doi.org/10.1016/j.diabres.2020.108184Get rights and content

Keywords

COVID-19, T2DM
Diabetes mellitus
Angiotensin-converting enzyme 2
Dapagliflozin
Insulin
Metformin

Cited by (0)

View Abstract